In summary, lncRNA PAXIP1‐AS1 promoted cell viability and migration of hPASMCs via ETS1/WIPF1/RhoA, which might provide a potential therapeutic target for PAH treatment. This evidence concerns the gene PAXIP1 and pulmonary arterial hypertension.